ERK1/2 in immune signalling

被引:67
|
作者
Lucas, Richard M. [1 ]
Luo, Lin [1 ]
Stow, Jennifer L. [1 ]
机构
[1] Univ Queensland, Ctr Inflammat & Dis Res, St Lucia, Qld 4072, Australia
基金
澳大利亚研究理事会; 英国医学研究理事会;
关键词
NF-KAPPA-B; ACTIVATED PROTEIN-KINASES; TOLL-LIKE RECEPTORS; MAP-KINASE; PATTERN-RECOGNITION; PHOSPHORYLATION SITES; LINKS ERK; TPL-2; JNK; MACROPHAGES;
D O I
10.1042/BST20220271
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Extracellular signal-related kinases 1 and 2 (ERK1/2) are the final components of the mitogen-activated protein kinase (MAPK) phosphorylation cascade, an integral module in a diverse array of signalling pathways for shaping cell behaviour and fate. More recently, studies have shown that ERK1/2 plays an essential role downstream of immune receptors to elicit inflammatory gene expression in response to infection and cell or tissue damage. Much of this work has studied ERK1/2 activation in Toll-like receptor (TLR) pathways, providing mechanistic insights into its recruitment, compartmentalisation and activation in cells of the innate immune system. In this review, we summarise the typical activation of ERK1/2 in growth factor receptor pathways before discussing its known roles in immune cell signalling with a focus downstream of TLRs. We examine emerging research uncover-ing evidence of dysfunctional ERK1/2 signalling in inflammatory diseases and discuss the potential therapeutic benefit of targeting ERK1/2 pathways in inflammation.
引用
收藏
页码:1341 / 1352
页数:12
相关论文
共 50 条
  • [1] MAPK signalling: ERK5 versus ERK1/2
    Nishimoto, Satoko
    Nishida, Eisuke
    EMBO REPORTS, 2006, 7 (08) : 782 - 786
  • [2] Tumour cell survival signalling by the ERK1/2 pathway
    Balmanno, K.
    Cook, S. J.
    CELL DEATH AND DIFFERENTIATION, 2009, 16 (03): : 368 - 377
  • [3] Anaplasma phagocytophilum AptA modulates Erk1/2 signalling
    Sukumaran, Bindu
    Mastronunzio, Juliana E.
    Narasimhan, Sukanya
    Fankhauser, Sarah
    Uchil, Pradeep D.
    Levy, Roie
    Graham, Morven
    Colpitts, Tonya Michelle
    Lesser, Cammie F.
    Fikrig, Erol
    CELLULAR MICROBIOLOGY, 2011, 13 (01) : 47 - 61
  • [4] Tumour cell survival signalling by the ERK1/2 pathway
    K Balmanno
    S J Cook
    Cell Death & Differentiation, 2009, 16 : 368 - 377
  • [5] DIFFERENCES IN THE ERK1/2 SIGNALLING PATHWAY OF A1-ADRENOCEPTOR SUBTYPES
    Carceller Zazo, E.
    Perez Aso, M.
    Noguera Romero, M. A.
    D'Ocon Navaza, M. P.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 54 - 54
  • [6] Particle induced Erk1/2 and AKT signalling is mediated by β1-integrin
    Bierhals, K
    Berken, A
    Abel, J
    Unfried, K
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 : R131 - R131
  • [7] ERK5 Signalling and Resistance to ERK1/2 Pathway Therapeutics: The Path Less Travelled?
    Cook, Simon J.
    Lochhead, Pamela A.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [8] The role of the ERK1/2 signalling pathway in the pathogenesis of female stress urinary incontinence
    Huang, Qiong
    Jin, Hangmei
    Xie, Zhenwei
    Wang, Min
    Chen, Jian
    Zhou, Yong
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2013, 41 (04) : 1242 - 1251
  • [9] Control of cell death and mitochondrial fission by ERK1/2 MAP kinase signalling
    Cook, Simon J.
    Stuart, Kate
    Gilley, Rebecca
    Sale, Matthew J.
    FEBS JOURNAL, 2017, 284 (24) : 4177 - 4195
  • [10] Mitogen-activated protein kinase signalling and ERK1/2 bistability in asthma
    Alam, R.
    Gorska, M. M.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2011, 41 (02): : 149 - 159